Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase III
Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial 8/28/2014 8:54:31 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-APOCIII Rx In Patients With FCS 8/28/2014 11:34:02 AM
FDA Grants Amgen (AMGN) Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 8/27/2014 8:03:55 AM
RedHill Biopharma Ltd. (RDHL) Provides Update On Expansion Of Ongoing RHB-105 Phase 3 Study, Targeting Broadened H. Pylori Indication Authorized By FDA 8/27/2014 7:45:56 AM
Regado Biosciences, Inc. (RGDO) Permanently Halts Enrollment In Lead Drug Trial 8/25/2014 6:04:48 AM
The Neurocritical Care Society Announces Trial Results & New Guidelines At Their 2014 Annual Meeting 8/26/2014 8:05:13 AM
ZS Pharma (ZSPH) To Present Late-Breaking Abstract Data From Phase 3 Trial Of ZS-9 In State Of The Art And Featured Research Session Oral Presentation At European Society of Cardiology Congress 8/26/2014 7:19:02 AM
La Jolla Pharmaceutical Company (LJPC) Announces First Patient Enrolled In Clinical Trial Of LJPC-501 In Hepatorenal Syndrome 8/25/2014 8:11:00 AM
Regeneron Pharmaceuticals, Inc. (REGN) And Sanofi (France) (SAN.PA) To Present Results From Four Phase 3 Alirocumab Trials In Hot Line Session At ESC Congress 2014 8/25/2014 8:04:35 AM
Janssen Research & Development Release: Data on XARELTO® At ESC Congress 2014 Hot Line Session Premieres First Prospective Study Of A Factor Xa Inhibitor In Elective Cardioversion 8/25/2014 8:46:58 AM
Adocia Launches Phase III Clinical Study In India Of Treatment For Diabetic Foot Ulcer 8/25/2014 10:15:49 AM
Update: OncoGenex Pharmaceuticals Inc. (OGXI) Phase 3 ENSPIRIT Trial Continuing As Planned 8/22/2014 6:05:19 AM
Amicus Therapeutics, Inc. (FOLD) Rockets On Positive Phase 3 Study Data For Rare Disease Drug 8/20/2014 5:57:00 AM
Long-Acting Version Of Baxter International, Inc. (BAX)'s Hemophilia A Drug BAX 855 Succeeds In Study 8/21/2014 9:19:47 AM
Eli Lilly and Company (LLY)'s Psoriasis Drug Ixekizumab Succeeds In Late-Stage Studies 8/21/2014 6:22:32 AM